Grace Therapeutics, Inc. Other Receivables, Net, Current
Grace Therapeutics, Inc. (GRCE) had Other Receivables, Net, Current of $20.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Notes › Nontrade Receivables
us-gaap:OtherReceivablesNetCurrent · last filed 2025-08-12
- 2025-06-30: Other Receivables, Net, Current $20.00K.
- 2025-03-31: Other Receivables, Net, Current $20.00K.
- 2024-12-31: Other Receivables, Net, Current $20.00K.
- 2024-09-30: Other Receivables, Net, Current $20.00K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2025-06-30 | $20.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $20.00K 10-Q · filed 2025-08-12 |
| 2024-12-31 | $20.00K 10-Q · filed 2025-02-13 |
| 2024-09-30 | $20.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $20.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $35.00K 10-K · filed 2025-06-23 |
| 2023-03-31 | $0.00 10-K · filed 2024-06-21 |
| 2021-03-31 | $18.00K 10-K · filed 2022-06-21 |
| 2020-03-31 | $25.00K 10-K · filed 2021-06-22 |
| 2019-03-31 | $5.00K 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |